BDNF Gene

BDNF Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">BDNF</th>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Brain-Derived Neurotrophic Factor</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>11p14.1</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding gene</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>627</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>113505</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000176697</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>P23560</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Neurotrophin family</td>
</tr>
<tr>
<td class="label">Receptors</td>
<td>TrkB (NTRK2), p75NTR (TNFRSF1B)</td>
</tr>
<tr>
<td class="label">Major Pathways</td>
<td>PI3K/Akt, MAPK/ERK, PLCγ</td>
</tr>
<tr>
<td class="label">Primary Disease Links</td>
<td>AD, PD, HD, Depression, Rett Syndrome</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/adhd" style="color:#ef9a9a">ADHD</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/autism" style="color:#ef9a9a">AUTISM</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-856feb98" style="color:#ce93d8" title="Score: 0.73">Hippocampal CA3-CA1 c

BDNF Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">BDNF</th>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Brain-Derived Neurotrophic Factor</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>11p14.1</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding gene</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>627</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>113505</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000176697</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>P23560</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Neurotrophin family</td>
</tr>
<tr>
<td class="label">Receptors</td>
<td>TrkB (NTRK2), p75NTR (TNFRSF1B)</td>
</tr>
<tr>
<td class="label">Major Pathways</td>
<td>PI3K/Akt, MAPK/ERK, PLCγ</td>
</tr>
<tr>
<td class="label">Primary Disease Links</td>
<td>AD, PD, HD, Depression, Rett Syndrome</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/adhd" style="color:#ef9a9a">ADHD</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/autism" style="color:#ef9a9a">AUTISM</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-856feb98" style="color:#ce93d8" title="Score: 0.73">Hippocampal CA3-CA1 circuit rescue via n...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">2350 edges</a></td>
</tr>
</table>

BDNF Gene

Introduction

Brain-Derived Neurotrophic Factor (BDNF) is the most widely expressed neurotrophin in the mammalian brain and plays essential roles in neuronal development, survival, synaptic plasticity, and cognitive function. Discovered in the 1980s as a member of the neurotrophin family, BDNF has become one of the most studied neurotrophic factors in the context of neurodegenerative diseases, psychiatric disorders, and neural repair. [@binder2004]

BDNF is unique among neurotrophins in that its expression is highly activity-dependent, with neuronal activity, learning, exercise, and environmental enrichment all increasing BDNF transcription. This activity-dependent regulation makes BDNF a critical mediator of experience-dependent neural plasticity.

Molecular Biology

Gene Structure

The BDNF gene is located on chromosome 11p14.1 and consists of 11 exons and 9 functional promoters, making it one of the most complexly regulated neurotrophin genes. This complex promoter architecture allows for tissue-specific, developmental stage-specific, and activity-dependent regulation.

Key exons:

• Exon 1: Brain-specific promoter
• Exon 2: Activity-dependent promoter (contains CREB binding sites)
• Exon 3-9: Additional regulatory elements

Protein Processing

BDNF is synthesized as a precursor protein (pro-BDNF, ~32 kDa) that undergoes proteolytic processing to generate the mature BDNF (~14 kDa):[@cowley1994]

The balance between pro-BDNF and mature BDNF is critical for neural development and plasticity.

Receptor Signaling

TrkB Receptor

BDNF signals primarily through the TrkB (Tropomyosin receptor kinase B, encoded by NTRK2) receptor:[@huang2003]

Receptor structure:

• Extracellular domain: Leucine-rich repeat domains for ligand binding
• Transmembrane domain: Single pass receptor
• Cytoplasmic domain: Tyrosine kinase domain

• Full-length TrkB (TrkB-FL): Contains cytoplasmic kinase domain
• TrkB-T1: Truncated isoform acting as dominant-negative

Signaling Pathways

BDNF binding to TrkB activates multiple downstream cascades:[@gomes2012]

PI3K/Akt Pathway

• recruitment of PI3K to phosphorylated TrkB phosphotyrosines
• Akt phosphorylation promotes neuronal survival
• Key targets: BAD phosphorylation (inhibition), mTOR activation

MAPK/ERK Pathway

• Ras activation recruited via Shc adaptor
• MEK phosphorylation activates ERK1/2
• ERK promotes:
• Gene transcription (via CREB)
• Synaptic plasticity
• Neuronal differentiation

PLCγ Pathway

• PLCγ recruitment and activation
• IP3 and DAG production
• Calcium release from internal stores
• PKC activation
• Synaptic plasticity mechanisms

p75NTR Signaling

The p75 neurotrophin receptor can also bind BDNF, with context-dependent effects:

Pro-BDNF/p75NTR signaling:

• Induces apoptosis during development
• Activates JNK pathway
• Mediates pruneUnused synapses

• Can enhance survival in some contexts
• May function as co-receptor with TrkB
• Regulation of synaptic plasticity

Expression and Regulation

Brain Region Distribution

BDNF is highly expressed in:[@kowianski2018]

• Hippocampus: CA1-CA3 pyramidal neurons, dentate gyrus granule cells
• Cortex: Layers II-III, V pyramidal neurons
• Basal forebrain: Cholinergic neurons
• Substantia nigra: Dopaminergic neurons
• Cerebellum: Purkinje cells
• Amygdala: Principal neurons

Activity-Dependent Regulation

BDNF expression is highly regulated by neuronal activity:

Upregulating factors:

• Synaptic activity: Calcium influx through NMDA receptors
• Seizure activity: Kainate-induced seizures dramatically increase BDNF
• Learning: Hippocampal-dependent learning tasks
• Exercise: Voluntary and forced exercise
• Environmental enrichment: Complex housing environments
• Antidepressants: SSRIs, ECT, ketamine

• Stress: Glucocorticoids reduce BDNF
• Aging: BDNF expression declines with age
• Neurodegeneration: Reduced BDNF in AD, PD, HD brains

Roles in the Nervous System

Development

During neural development, BDNF mediates:[@carroll1995]

Synaptic Plasticity

BDNF is a critical mediator of activity-dependent synaptic changes:[@pizzorusso2002]

Long-term potentiation (LTP):

• BDNF enhances LTP in hippocampus
• TrkB activation required for LTP maintenance
• BDNF application rescues LTP deficits

• Pro-BDNF/p75NTR signaling mediates LTD
• Synaptic prune during development

• Scaling of synaptic strength
• Regulation of excitation/inhibition balance

Memory and Cognition

BDNF is essential for learning and memory:[@kowianski2018]

• Hippocampal-dependent learning tasks impaired in BDNF knockout mice
• BDNF Val66Met polymorphism affects:
• Hippocampal volume
• Memory performance
• Treatment response in depression

Disease Associations

Alzheimer's Disease

BDNF alterations in AD:[@allen2013]

Expression changes:

• BDNF protein reduced in AD hippocampus
• BDNF mRNA decreased in AD brain
• Correlation between BDNF and cognitive function

• Amyloid-beta reduces BDNF expression
• Tau pathology affects BDNF signaling
• Synaptic loss correlates with BDNF reduction

• AAV-BDNF gene therapy
• Recombinant BDNF protein
• TrkB agonists (7,8-DHF, BDNF mimetics)
• Exercise and cognitive training

• AAV-BDNF improves cognition in AD models[@liu2015]
• Reduces amyloid pathology
• Enhances synaptic markers

Parkinson's Disease

BDNF supports dopaminergic neurons:[@levy2018]

Dopaminergic protection:

• Supports substantia nigra neuron survival
• Protects against MPTP toxicity
• Maintains tyrosine hydroxylase expression

• AAV-BDNF to striatum (clinical trials)
• AAV-BDNF with AAV-GDNF combinations
• Stem cell-derived BDNF

Huntington's Disease

BDNF is crucial for striatal neuron function:[@colucci-d2008]

Dysregulation in HD:

• BDNF expression reduced in HD brain
• Impaired BDNF transport in HD
• Mutant huntingtin affects BDNF transcription

• Restore BDNF levels
• AAV-BDNF gene therapy
• TrkB agonist therapy

Major Depressive Disorder

BDNF is a key mediator of antidepressant efficacy:[@tapia2011]

Clinical findings:

• Reduced serum BDNF in depression
• Antidepressants increase BDNF
• BDNF Val66Met affects treatment response

• SSRIs increase BDNF expression
• ECT dramatically elevates BDNF
• Ketamine rapid antidepressant effects involve BDNF

Other Conditions

Rett Syndrome:

• Reduced BDNF in mouse models
• BDNF therapy rescues phenotypes

• BDNF contributes to epileptogenesis
• Aberrant mossy fiber sprouting

Therapeutic Targeting

Delivery Strategies

| Approach | Advantages | Limitations | Status |
|----------|-----------|------------|--------|
| Recombinant BDNF | Well-characterized | BBB penetration | Preclinical |
| AAV-BDNF | Long-term expression | Immune response | Clinical trials |
| TrkB agonists | Oral delivery | Specificity | Preclinical |
| Exercise | Natural, safe | Variable | Proven |
| Antidepressants | FDA-approved | Indirect | Approved |

TrkB Agonists

Small molecule TrkB agonists being developed:

• 7,8-Dihydroxyflavone (7,8-DHF): First-generation agonist
• Nor-BDNF: BDNF peptiderivative
• TrkB-selective compounds: Newer generations

Gene Therapy

AAV-mediated BDNF delivery:[@gomes2012]

• AAV2/9 serotypes for CNS
• Promoters for neuron-specific expression
• Regulated expression systems
• Safety considerations

Animal Models

BDNF Knockout Mice

Complete BDNF knockout is embryonic lethal, demonstrating the essential role during development. Conditional knockout models have provided crucial insights:

forebrain-specific knockout:

• Impaired LTP
• Deficits in hippocampal-dependent memory
• Reduced anxiety-like behavior

• Loss of cortical and hippocampal neurons
• Impaired synaptic plasticity
• Behavioral abnormalities

BDNF Overexpression Models

Transgenic overexpression:

• Enhanced learning and memory
• Increased synaptic density
• Resistance to metabolic stress

• AAV-BDNF in various brain regions
• Rescue of cognitive deficits in AD models
• Neuroprotection in PD models

Pharmacological Modulation

TrkB Agonists

| Compound | Mechanism | Stage | Notes |
|----------|-----------|-------|-------|
| 7,8-DHF | TrkB agonist | Preclinical | First-generation |
| Nor-BDNF | BDNF derivative | Research | More stable |
| R13 | TrkB-selective | Preclinical | Oral bioavailability |
| ANA-12 | TrkB antagonist | Research | Used to study BDNF role |

Anxiolytic and Antidepressant Effects

BDNF mediates the effects of:

• SSRIs: Increase BDNF expression
• ketamine: Rapid antidepressant via TrkB
• Exercise: Natural BDNF enhancer
• ECS: Potent BDNF inducer

Genetic Variants

BDNF Val66Met Polymorphism

The functional Val66Met polymorphism (rs6265) affects:

• Activity-dependent secretion
• Hippocampal function
• Memory performance
• Treatment response in depression
• Risk for various neuropsychiatric conditions

Other Common Variants

• BDNF promoter polymorphisms
• 5' UTR variants
• 3' UTR regulatory variants
• Copy number variants

Cross-Links

• [Brain-Derived Neurotrophic Factor](/proteins/brain-derived-neurotrophic-factor) — protein information
• [TrkB Signaling Pathway](/mechanisms/trkb-signaling)
• [Neurotrophin Signaling in Neurodegeneration](/mechanisms/neurotrophin-signaling)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Huntington's Disease](/mechanisms/huntington-pathway)
• [Hippocampus](/brain-regions/hippocampus)
• [Dopaminergic Neurons](/entities/dopaminergic-neurons)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)

External Links

• [NCBI Gene: BDNF](https://www.ncbi.nlm.nih.gov/gene/627)
• [UniProt: BDNF](https://www.uniprot.org/uniprot/P23560)
• [Ensembl: BDNF](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000176697)
• [OMIM: BDNF](https://www.omim.org/entry/113505)
• [Allen Human Brain Atlas: BDNF](https://human.brain-map.org/microarray/search/show?search_term=BDNF)
• [ClinicalTrials.gov: BDNF](https://clinicaltrials.gov/search?term=BDNF)

References

Pathway Diagram

The following diagram shows key molecular relationships for BDNF Gene based on knowledge graph edges:

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Hippocampal CA3-CA1 circuit rescue via neurogenesis and synaptic preservation](/hypothesis/h-856feb98) — <span style="color:#81c784;font-weight:600">0.73</span> · Target: BDNF
• [Vocal Cord Neuroplasticity Stimulation](/hypothesis/h-e0183502) — <span style="color:#ffd54f;font-weight:600">0.52</span> · Target: CHR2/BDNF
• [Vagal Afferent Microbial Signal Modulation](/hypothesis/h-ee1df336) — <span style="color:#ffd54f;font-weight:600">0.51</span> · Target: GLP1R, BDNF

Pathway Diagram

The following diagram shows the key molecular relationships involving BDNF Gene discovered through SciDEX knowledge graph analysis:

Associated Diseases

• Als — associated with

• ALS — associated with

• Alzheimer — associated with

• Alzheimer Disease — associated with

• alzheimer_s_disease — associated with

• Alzheimer's disease — associated with

• Alzheimer's Disease — associated with

• Alzheimer'S Disease — associated with

• Amyotrophic Lateral Sclerosis — associated with

• dementia — associated with

• Dementia — associated with

• Parkinson — associated with

• Parkinson Disease — associated with

• Parkinson's disease — associated with

• PARKINSON'S DISEASE — causes

• vascular dementia — biomarker for